Free Trial
ASX:EPN

Epsilon Healthcare (EPN) Stock Price, News & Analysis

Epsilon Healthcare logo

About Epsilon Healthcare Stock (ASX:EPN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$7.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.

Receive EPN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epsilon Healthcare and its competitors with MarketBeat's FREE daily newsletter.

EPN Stock News Headlines

Israel-Iran WAR Could Destroy Trump's Presidency
The missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't have happened at a worse time. Trump is already dealing with Biden's $34 trillion debt bomb AND now a Middle East war. This is exactly what the "resistance" has been waiting for.
See More Headlines

EPN Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Epsilon Healthcare investors own include Rhythm Biosciences (RHY), Vicarious Surgical (RBOT) and BBX Minerals (BBX).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:EPN
CIK
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.93 million
Net Margins
-186.84%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.21 million
Price / Cash Flow
N/A
Book Value
A$0.03 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$7.21 million
Optionable
Not Optionable
Beta
0.92
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:EPN) was last updated on 6/28/2025 by MarketBeat.com Staff
From Our Partners